NMN (Nicotinamide Mononucleotide) vs NR (Nicotinamide Riboside)
Both NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are NAD+ precursors marketed for energy, mitochondrial health, and healthspan. The actual evidence base differs more than the molecules do.
VS
| Factor | NMN (Nicotinamide Mononucleotide) | NR (Nicotinamide Riboside) |
|---|---|---|
| Mechanism | Direct NAD+ precursor | Intermediate → NMN → NAD+ |
| Human trials | Fewer, growing fast | More, established safety |
| Typical dose | 250–500 mg | 300 mg |
| Timing | Morning, with fat | Morning |
| Cost per month | $$$ | $$$ |
| FDA status | Contested (supplement) | Confirmed supplement |
When to pick each
NMN (Nicotinamide Mononucleotide)
Pick NMN if…
You want the most direct precursor and you're comfortable operating at the edge of emerging human data. The mechanistic case is strong; the trial base is catching up.
NR (Nicotinamide Riboside)
Pick NR if…
You prefer the molecule with the longest track record of human safety and efficacy data. The endpoint — raised NAD+ — is the same.
Frequently asked
- Do NAD boosters actually extend lifespan?
- Not proven in humans. Preclinical data is strong for mitochondrial function and metabolic markers. Healthspan signals are real; lifespan claims are speculative.
- Can I just take niacin instead?
- Niacin raises NAD+ but causes flushing at effective doses. NMN and NR bypass the flush response at the cost of being much more expensive per mg.
- Which is more bioavailable?
- NMN and NR both reach systemic NAD+ via overlapping pathways. At equivalent doses they produce similar serum NAD+ changes in human trials.
Want our pick for you?
Comparisons are useful, but the right answer depends on your goals, diet, medications, and what's already in your stack. Take the 2-minute quiz — we'll pick the form and dose for you.
Build my plan